KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Free Cash Flow (2018 - 2026)

Castle Biosciences' Free Cash Flow history spans 8 years, with the latest figure at $19.7 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 17.56% to $19.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.3 million, a 22.48% decrease, with the full-year FY2025 number at $28.3 million, down 22.48% from a year prior.
  • Free Cash Flow hit $19.7 million in Q4 2025 for Castle Biosciences, up from $616000.0 in the prior quarter.
  • Over the last five years, Free Cash Flow for CSTL hit a ceiling of $26.9 million in Q4 2021 and a floor of -$39.3 million in Q3 2021.
  • Historically, Free Cash Flow has averaged -$525650.0 across 5 years, with a median of -$4.8 million in 2021.
  • The widest YoY moves for Free Cash Flow: up 6003.51% in 2021, down 1216.17% in 2021.
  • Tracing CSTL's Free Cash Flow over 5 years: stood at $26.9 million in 2021, then tumbled by 139.01% to -$10.5 million in 2022, then soared by 285.59% to $19.5 million in 2023, then fell by 13.81% to $16.8 million in 2024, then increased by 17.56% to $19.7 million in 2025.
  • Business Quant data shows Free Cash Flow for CSTL at $19.7 million in Q4 2025, $616000.0 in Q3 2025, and $18.7 million in Q2 2025.